Prior to irradiation, we first assessed our mesothelioma cell lines for surface expression of three markers commonly found on tumor cells, and of particular relevance to cancer immunotherapy: MHC-I, MHC-II and PD-L1. This evidence concerns the gene CD274 and cancer.